FMO5 and chronic granulomatous disease: Using human neutrophils from healthy controls or from patients with the chronic granulomatous disease (CGD), which lacks NADPH Oxidase, it was demonstrated that NET release can indeed be induced by mitochondrial ROS production (Vorobjeva, 2020).